At present, China's medical device industry market is about 400 billion yuan, and it is increasing at a rate of 20% per year, a veritable uprising industry." said Fan Yubo, chairman of the China Biomedical Engineering Society, was on the 28th in 2012 World Medical Physics and Biomedical Engineering conference.

   The conference, entitled "Technology for Health", was held in Beijing from May 26th to 31st. Top experts, scholars and medical device companies of the biomedical engineering community from more than 80 countries and regions were invited to attend this conference.

“Here, we learn new knowledge form new hypotheses, plan new experiments, and develop new technologies for health care, and building friendships," said Dr. Herbert Eit, President of the International Federation of Medical and Biological Engineering.

    Biomedical engineering is an emerging interdisciplinary subject that integrates biology, medicine, engineering and other disciplines, a powerful driving force for the development of modern medicine. From small blood pressure monitors to large surgical robots, they are closely related to people's lives.

   Biomedical engineering originated in Europe and America. In recent years, Asia, especially China, has rapidly emerged as an important force in this field. "Only from the venue of the conference can it reflect that biomedical engineering is valued and improved in China Asia," said Dr. Barry Allen, President of the International Federation of Medical Physics and Medical Engineering.

    Professor Fan Yubo said that more than 70% of China's high-end medical devices rely on imports at present, of which high-end knee joints, pacemakers etc are almost 100% dependent on imports.

   "We have not completely said goodbye to the history of using syringe filled with a whole train to exchange nuclear magnetic resonance instrument—import high-end equipment, and export low-end products. However, it should be noted that with the efforts in recent years, the import and export structure of medical equipment in China is being optimized. More and more mid-range products have joined the ranks of exporters." Fan Yubo said.

    Take Shenzhen Mindray Biomedical Electronics Co., Ltd as an example. Since  listing on the NYSE in 2006, it has insisted on investing 10% of its annual sales in research and development. Now the products are exported to 196 countries and regions around the world, and overseas sales account for more than 60% of the company's annual sales.

   At present, there are 15,000 medical device companies in production and more than 300,000 in marketing. The rapid development of the industry has a strong demand for professionals.

   "Much more universities in China have established this major because of the need to closely follow the frontiers of biology, chemistry, materials etc, and professional talent training is an urgent task." said Fan Yubo.